This mechanism has been suggested to underlie the effect of IGF-I on tau phosphorylation in Alzheimer’s disease; amyloid-β stimulates local astrocytes to release IGFBP-3, which in turn inhibits IGF-I-mediated suppression of tau phosphorylation63. Here, MAPT is linked to Alzheimer disease.